Unveiling the Potential of Cmax f2 Factor Applied to Pilot Bioavailability/Bioequivalence Studies-A Case Study with Pazopanib Drug ProductsPHARMACEUTICSIF5.52024-12-110OAAI
Effect of zamicastat on blood pressure and heart rate response to cold pressor test: A double-blind, randomized, placebo-controlled study in healthy subjectsBRITISH JOURNAL OF CLINICAL PHARMACOLOGYIF32024-07-061PRE
A Two-Way Proposal for the Determination of Bioequivalence for Narrow Therapeutic Index Drugs in the European UnionPHARMACEUTICSIF5.52024-04-281OAAI
Predictive Potential of Cmax Bioequivalence in Pilot Bioavailability/Bioequivalence Studies, through the Alternative f2 Similarity Factor MethodPHARMACEUTICSIF5.52023-10-201OAAI
Alternative Analysis Approaches for the Assessment of Pilot Bioavailability/Bioequivalence StudiesPHARMACEUTICSIF5.52023-05-074OAAI
Untangling Absorption Mechanisms and Variability in Bioequivalence Studies Using Population AnalysisPHARMACEUTICAL RESEARCHIF4.32021-12-210PRE
A Proposed Approach for the Determination of the Bioequivalence Acceptance Range for Narrow Therapeutic Index Drugs in the European UnionCLINICAL PHARMACOLOGY & THERAPEUTICSIF5.52021-11-035PREAI
A Single Dose of Marine Chlorella vulgaris Increases Plasma Concentrations of Lutein, β-Carotene and Zeaxanthin in Healthy Male VolunteersANTIOXIDANTSIF6.62021-07-2212OAAI
Albumin-binding domain from Streptococcus zooepidemicus protein Zag as a novel strategy to improve the half-life of therapeutic proteinsJOURNAL OF BIOTECHNOLOGYIF3.92017-07-0118PREAI
Analysis of cocaine and nicotine metabolites in wastewater by liquid chromatography-tandem mass spectrometry. Cross abuse index patterns on a major communitySCIENCE OF THE TOTAL ENVIRONMENTIF82014-07-0153OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向